Detalhe da pesquisa
1.
Effective retreatment with osimertinib in CNS-relapsed epidermal growth factor receptor-mutant non-small cell lung cancer patient following resection and adjuvant osimertinib.
Anticancer Drugs
; 35(1): 86-88, 2024 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37227039
2.
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies.
Expert Opin Emerg Drugs
; : 1-16, 2024 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38572595
3.
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer.
Curr Oncol Rep
; 25(9): 1017-1029, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37378881
4.
Antibody-drug conjugates for lung cancer in the era of personalized oncology.
Semin Cancer Biol
; 69: 268-278, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31899248
5.
Impact of Baseline Versus Intercurrent Steroids Administration on Upfront Chemo-Immunotherapy for Advanced Non-Small Cell Lung Cancer (NSCLC).
Int J Mol Sci
; 23(18)2022 Sep 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36142204
6.
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines).
Curr Oncol Rep
; 23(11): 126, 2021 08 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34453261
7.
PD-(L)1 inhibitors as single-agent or in combination with chemotherapy for advanced, PD-L1-high non-small cell lung cancer: a meta-analysis.
Future Oncol
; 17(32): 4415-4424, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34402681
8.
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Cancer Immunol Immunother
; 69(7): 1189, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32347358
9.
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Cancer Immunol Immunother
; 69(7): 1177-1187, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32140762
10.
Clinical consideration for choosing combination therapies in advanced non-small-cell lung cancer: age, Eastern Cooperative Organization performance status 2, steroids and antibiotics.
Future Oncol
; 16(23): 1683-1690, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32479119
11.
Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors.
Int J Mol Sci
; 21(23)2020 Nov 28.
Artigo
Inglês
| MEDLINE | ID: mdl-33260538
12.
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives.
Oncol Ther
; 2024 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38483781
13.
Navigating challenges in EGFR exon 20 insertions: The PAPILLON trial unravels the promise of amivantamab-chemotherapy.
Med
; 5(1): 1-3, 2024 Jan 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38218173
14.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Eur J Cancer
; 202: 114006, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38489861
15.
Bone-specific response according to MDA criteria predicts immunotherapy efficacy among advanced non-small cell lung cancer (NSCLC) patients.
J Cancer Res Clin Oncol
; 149(5): 1835-1847, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-35750899
16.
The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks.
Drugs Context
; 122023.
Artigo
Inglês
| MEDLINE | ID: mdl-37168875
17.
Predictors of survival to immunotherapy and chemoimmunotherapy in non-small cell lung cancer: A meta-analysis.
J Natl Cancer Inst
; 115(1): 29-42, 2023 01 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36322815
18.
Challenges in the management of advanced NSCLC among Italian oncologists: a 2019 national survey unfolds regional disparities.
Tumori
; 109(1): 105-111, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35120426
19.
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians.
Drug Saf
; 46(9): 819-833, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37341925
20.
Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond.
Biomolecules
; 13(12)2023 12 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38136673